Oral Metronidazole (Flagyl) Dosing
The dosing of oral metronidazole varies significantly by indication, ranging from 250 mg three times daily to 2 grams as a single dose, with specific regimens determined by the infection being treated.
Dosing by Clinical Indication
Trichomoniasis
- Single-dose regimen: 2 grams orally as a single dose (preferred for compliance, achieves 90-95% cure rates) 1
- Alternative: 500 mg orally twice daily for 7 days (may minimize reinfection and provide higher cure rates in some comparative studies) 1, 2
- For pregnant patients beyond the first trimester, use the 7-day regimen rather than single-dose to avoid higher fetal serum levels 2
Bacterial Vaginosis
- 500 mg orally twice daily for 7 days (recommended by CDC and ACOG) 1
- Alternative: 250 mg orally three times daily for 7 days 1
Giardiasis
- 250 mg orally three times daily for 5-7 days 1
- Pediatric dosing: 15 mg/kg/day divided into three doses for 5 days 1
- Important caveat: Tinidazole is now preferred as first-line therapy; metronidazole is an alternative 1
Amebiasis
- Acute intestinal amebiasis: 750 mg orally three times daily for 5-10 days 2
- Amebic liver abscess: 500-750 mg orally three times daily for 5-10 days 2
- Pediatric: 35-50 mg/kg/24 hours divided into three doses for 10 days 2
C. difficile Infection (CDI)
- Critical update: Metronidazole is NO LONGER first-line therapy for CDI 1, 3
- For non-severe CDI: 500 mg orally three times daily for 10 days ONLY when vancomycin (125 mg four times daily) or fidaxomicin is unavailable 1, 3
- Vancomycin and fidaxomicin have superior cure rates (97% vs 84% overall; 97% vs 76% in severe disease) 1
- For fulminant CDI: Intravenous metronidazole 500 mg every 8 hours PLUS oral vancomycin 500 mg four times daily 4, 3
- Never use metronidazole for recurrent CDI beyond the first episode due to cumulative neurotoxicity risk 1, 3
Anaerobic Bacterial Infections
- 7.5 mg/kg orally every 6 hours (approximately 500 mg for a 70 kg adult) 2
- Maximum: 4 grams per 24 hours 2
- Usual duration: 7-10 days; bone/joint, lower respiratory tract, and endocardium infections may require longer treatment 2
Critical Safety Considerations
Neurotoxicity Warning
- Avoid repeated or prolonged courses due to risk of cumulative and potentially irreversible neurotoxicity 1
- This is particularly important in CDI where multiple treatment courses may be tempting but should be avoided 1, 3
Special Populations
- Elderly patients: Monitor serum levels as pharmacokinetics may be altered; adjust dosing accordingly 2
- Severe hepatic disease: Use doses below usual recommendations with close monitoring of plasma levels and toxicity 2
- Anuric patients: No specific dose reduction needed as metabolites are rapidly removed by dialysis 2
- Pregnancy: Contraindicated in first trimester; use 7-day regimens (not single-dose) if treatment is essential after first trimester 2
Drug Interactions
- Avoid alcohol during treatment and for 24 hours after completion (disulfiram-like reaction) 1
- Important interactions with disulfiram and warfarin 5
Common Pitfalls to Avoid
- Do not use metronidazole as first-line for CDI - vancomycin or fidaxomicin are superior 1, 3
- Do not use metronidazole for second or subsequent CDI recurrences - neurotoxicity risk outweighs benefits 1, 3
- Do not extend treatment courses unnecessarily - cumulative neurotoxicity is a real concern 1
- Do not use single-dose regimens in pregnancy - higher serum levels reach fetal circulation 2
- Do not exceed 4 grams per 24 hours for anaerobic infections 2